{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:34:08Z","timestamp":1790555648935,"version":"4.1.0"},"reference-count":238,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"UKZN"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Normal pregnancy is associated with multiple changes in the coagulation and the fibrinolytic system. In contrast to a non-pregnant state, pregnancy is a hypercoagulable state where the level of VWF increases by 200\u2013375%, affecting coagulation activity. Moreover, in this hypercoagulable state of pregnancy, preeclampsia is exacerbated. ADAMTS13 cleaves the bond between Tyr1605 and Met1606 in the A2 domain of VWF, thereby reducing its molecular weight. A deficiency of ADAMTS13 originates from mutations in gene or autoantibodies formed against the protease, leading to defective enzyme production. Von Willebrand protein is critical for hemostasis and thrombosis, promoting thrombus formation by mediating the adhesion of platelets and aggregation at high shear stress conditions within the vessel wall. Mutations in VWF disrupts multimer assembly, secretion and\/or catabolism, thereby influencing bleeding. VWF is the primary regulator of plasma ADAMTS13 levels since even minute amounts of active ADAMTS13 protease have a significant inhibitory effect on inflammation and thrombosis. VWF is released as a result of endothelial activation brought on by HIV infection. The SARS-CoV-2 infection promotes circulating proinflammatory cytokines, increasing endothelial secretion of ultra large VWF that causes an imbalance in VWF\/ADAMTS13. Raised VWF levels corresponds with greater platelet adhesiveness, promoting a thrombotic tendency in stenotic vessels, leading to increased shear stress conditions.<\/jats:p>","DOI":"10.3390\/ijms26094103","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T11:47:41Z","timestamp":1745581661000},"page":"4103","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A Disintegrin and Metalloprotease with Thrombospondin Motif, Member 13, and Von Willebrand Factor in Relation to the Duality of Preeclampsia and HIV Infection"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0928-4620","authenticated-orcid":false,"given":"Prelene","family":"Naidoo","sequence":"first","affiliation":[{"name":"Optics & Imaging Centre, Doris Duke Medical Research Institute, University of KwaZulu-Natal, 719 Umbilo Road, Congella, Durban 4013, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6917-2191","authenticated-orcid":false,"given":"Thajasvarie","family":"Naicker","sequence":"additional","affiliation":[{"name":"Optics & Imaging Centre, Doris Duke Medical Research Institute, University of KwaZulu-Natal, 719 Umbilo Road, Congella, Durban 4013, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2024, July 15). Maternal Mortality. 16 May 2023. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/maternal-mortality."},{"key":"ref_2","unstructured":"UNICEF Data (2024, July 15). Maternal Mortality Rates and Statistics. 21 June 2023. Available online: https:\/\/data.unicef.org\/topic\/maternal-health\/maternal-mortality\/."},{"key":"ref_3","first-page":"1","article-title":"Will South Africa meet the Sustainable Development Goals target for maternal mortality by 2030?","volume":"114","author":"Pillay","year":"2024","journal-title":"SAMJ S. Afr. Med. J."},{"key":"ref_4","unstructured":"National Department of Health (2023, July 18). Saving Mothers: Executive Summary 2020\u20142022: Includes Data for COVID-19 Pandemic. Pretoria, Available online: https:\/\/www.health.gov.za\/wp-content\/uploads\/2023\/10\/Saving-Mothers-Executive-Summary-2020-2022-1.pdf."},{"key":"ref_5","unstructured":"Moodley, J. (2020). Deaths from hypertensive disorders of pregnancy during 2017\u20132019: Declining trends in South Africa. Obstetrics and Gynaecology Forum, In House Publications."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.clp.2020.08.011","article-title":"Hypertensive disorders of pregnancy","volume":"47","author":"Booker","year":"2020","journal-title":"Clin. Perinatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.preghy.2021.09.008","article-title":"The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice","volume":"27","author":"Magee","year":"2022","journal-title":"Pregnancy Hypertens."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"100056","DOI":"10.1016\/j.xagr.2022.100056","article-title":"Association between preeclampsia and HIV: A case-control study in urban South Africa","volume":"2","author":"Sikhosana","year":"2022","journal-title":"AJOG Glob. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41572-023-00417-6","article-title":"Pre-eclampsia","volume":"9","author":"Dimitriadis","year":"2023","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1034\/j.1600-0412.2003.00220.x","article-title":"Quantitative analysis of trophoblast invasion in preeclampsia","volume":"82","author":"Naicker","year":"2003","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1053\/j.ackd.2013.02.003","article-title":"New developments in the pathogenesis of preeclampsia","volume":"20","author":"Naljayan","year":"2013","journal-title":"Adv. Chronic Kidney Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.thromres.2021.04.021","article-title":"Early ADAMTS13 testing associates with pre-eclampsia occurrence in antiphospholipid syndrome","volume":"203","author":"Bitsadze","year":"2021","journal-title":"Thromb. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.preghy.2021.12.008","article-title":"Rule-in and rule-out of pre-eclampsia using DELFIA Xpress PlGF 1\u20132-3 and sFlt-1: PlGF ratio","volume":"27","author":"Bremner","year":"2022","journal-title":"Pregnancy Hypertens."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Qu, H., and Khalil, R.A. (2022). Role of ADAM and ADAMTS disintegrin and metalloproteinases in normal pregnancy and preeclampsia. Biochem. Pharmacol., 206.","DOI":"10.1016\/j.bcp.2022.115266"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"ii75","DOI":"10.1093\/bja\/aev374","article-title":"Disorders of coagulation in pregnancy","volume":"115","author":"Katz","year":"2015","journal-title":"BJA Br. J. Anaesth."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Forstner, D., Guettler, J., and Gauster, M. (2021). Changes in maternal platelet physiology during gestation and their interaction with trophoblasts. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms221910732"},{"key":"ref_17","first-page":"S189","article-title":"Physiological changes in pregnancy","volume":"25","author":"Gangakhedkar","year":"2021","journal-title":"Indian J. Crit. Care Med. Peer-Rev. Off. Publ. Indian Soc. Crit. Care Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5005\/jp-journals-10006-2192","article-title":"A Comparative Study of Coagulation Profile in Normal Pregnancy, Mild Preeclampsia, and Severe Preeclampsia Patients","volume":"15","author":"Tadu","year":"2023","journal-title":"J. South Asian Fed. Obstet. Gynaecol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2147\/JBM.S273047","article-title":"DIC in pregnancy\u2013pathophysiology, clinical characteristics, diagnostic scores, and treatments","volume":"13","author":"Erez","year":"2022","journal-title":"J. Blood Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jtha.2023.10.022","article-title":"Alterations in the Von Willebrand Factor\/ADAMTS13 axis in preeclampsia","volume":"22","author":"Neave","year":"2023","journal-title":"J. Thromb. Haemost."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Woods, A.I., Paiva, J., Dos Santos, C., Alberto, M.F., and S\u00e1nchez-Luceros, A. (2023). From the discovery of ADAMTS13 to current understanding of its role in health and disease. Seminars in Thrombosis and Hemostasis, Thieme Medical Publishers.","DOI":"10.1055\/s-0042-1758059"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Grover, S.P., and Mackman, N. (2022). Anticoagulant SERPINs: Endogenous regulators of hemostasis and thrombosis. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.878199"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cca.2012.10.060","article-title":"Fibrinolytic system in preeclampsia","volume":"416","author":"Pinheiro","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Han, C., Huang, P., Lyu, M., and Dong, J. (2020). Oxidative stress and preeclampsia-associated prothrombotic state. Antioxidants, 9.","DOI":"10.3390\/antiox9111139"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/hiv.12952","article-title":"Managing HIV-associated inflammation and ageing in the era of modern ART","volume":"21","author":"Bloch","year":"2020","journal-title":"HIV Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1161\/ATVBAHA.122.318232","article-title":"Cardiovascular Disease and Thrombosis in HIV Infection","volume":"43","author":"Perkins","year":"2023","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_27","first-page":"1","article-title":"Platelet Dysfunction in HIV Patients: Assessing ART Risks","volume":"2","author":"Obeagu","year":"2024","journal-title":"Elite J. Sci. Res. Rev."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Kelwick, R., Desanlis, I., Wheeler, G.N., and Edwards, D.R. (2015). The ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin motifs) family. Genome Biol., 16.","DOI":"10.1186\/s13059-015-0676-3"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"19099","DOI":"10.1073\/pnas.0607264104","article-title":"Exosite interactions contribute to tension-induced cleavage of von Willebrand factor by the antithrombotic ADAMTS13 metalloprotease","volume":"103","author":"Gao","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1111\/jth.15873","article-title":"Mechanisms of ADAMTS13 regulation","volume":"20","author":"DeYoung","year":"2022","journal-title":"J. Thromb. Haemost."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e2013058","DOI":"10.4084\/mjhid.2013.058","article-title":"Proteolytic processing of von Willebrand factor by adamts13 and leukocyte proteases","volume":"5","author":"Lancellotti","year":"2013","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1146\/annurev-med-061813-013241","article-title":"ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura","volume":"66","author":"Zheng","year":"2015","journal-title":"Annu. Rev. Med."},{"key":"ref_33","unstructured":"Khemisi, M.M. (2020). Characterization of Autoantibodies to ADAMTS13 in HIV-Associated Thrombotic Thrombocytopenic Purpura. [Ph.D. Thesis, University of the Free State]."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/MOH.0000000000000169","article-title":"ADAMTS13 and von Willebrand factor interactions","volume":"22","author":"Zander","year":"2015","journal-title":"Curr. Opin. Hematol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1161\/ATVBAHA.111.223610","article-title":"Von Willebrand factor and ADAMTS13: A candidate couple for preeclampsia pathophysiology","volume":"31","author":"Stepanian","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/humu.20267","article-title":"Mechanisms of the interaction between twoADAMTS13 gene mutations leading to severe deficiency of enzymatic activity","volume":"27","author":"Peyvandi","year":"2006","journal-title":"Hum. Mutat."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1055\/s-0038-1673686","article-title":"ADAMTS13 Gene Mutations Influence ADAMTS13 Conformation and Disease Age-Onset in the French Cohort of Upshaw\u2013Schulman Syndrome","volume":"118","author":"Joly","year":"2018","journal-title":"Thromb. Haemost."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.bcp.2019.03.033","article-title":"A Disintegrin and Metalloproteinase (ADAM) and ADAM with thrombospondin motifs (ADAMTS) family in vascular biology and disease","volume":"164","author":"Zhong","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Lumangtad, L.A., and Bell, T.W. (2020). The signal peptide as a new target for drug design. Bioorg. Med. Chem. Lett., 30.","DOI":"10.1016\/j.bmcl.2020.127115"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Shelat, S.G., Ai, J., and Zheng, X.L. (2005). Molecular biology of ADAMTS13 and diagnostic utility of ADAMTS13 proteolytic activity and inhibitor assays. Seminars in Thrombosis and Hemostasis, Thieme Medical Publishers.","DOI":"10.1055\/s-2005-925472"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"26944","DOI":"10.1074\/jbc.M112.380535","article-title":"Rearranging Exosites in Noncatalytic Domains Can Redirect the Substrate Specificity of ADAMTS Proteases","volume":"287","author":"Gao","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1182\/blood-2013-11-538173","article-title":"Control of VWF A2 domain stability and ADAMTS13 access to the scissile bond of full-length VWF","volume":"123","author":"Lynch","year":"2014","journal-title":"Blood"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"41059","DOI":"10.1074\/jbc.C100515200","article-title":"Structure of von Willebrand Factor-cleaving Protease (ADAMTS13), a Metalloprotease Involved in Thrombotic Thrombocytopenic Purpura","volume":"276","author":"Zheng","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1074\/jbc.M504540200","article-title":"Zinc and Calcium Ions Cooperatively Modulate ADAMTS13 Activity","volume":"281","author":"Anderson","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Yang, J., Wu, Z., Long, Q., Huang, J., Hong, T., Liu, W., and Lin, J. (2020). Insights Into Immunothrombosis: The Interplay Among Neutrophil Extracellular Trap, von Willebrand Factor, and ADAMTS13. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.610696"},{"key":"ref_46","first-page":"91","article-title":"Thrombotic microangiopathies: Role of ADAMTS-13","volume":"62","author":"Adil","year":"2012","journal-title":"JPMA J. Pak. Med. Assoc."},{"key":"ref_47","first-page":"1968","article-title":"The role of the ADAMTS13 cysteine-rich domain in VWF binding and proteolysis","volume":"125","author":"Lane","year":"2015","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"19274","DOI":"10.1073\/pnas.0909755106","article-title":"Crystal structures of the noncatalytic domains of ADAMTS13 reveal multiple discontinuous exosites for von Willebrand factor","volume":"106","author":"Akiyama","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_49","first-page":"1713","article-title":"Extensive contacts between ADAMTS13 exosites and von Willebrand factor domain A2 contribute to substrate specificity","volume":"112","author":"Gao","year":"2008","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2138306","DOI":"10.1080\/09537104.2022.2138306","article-title":"Inherited ADAMTS13 mutations associated with Thrombotic Thrombocytopenic Purpura: A short review and update","volume":"34","author":"Morgan","year":"2023","journal-title":"Platelets"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"eabg4403","DOI":"10.1126\/sciadv.abg4403","article-title":"Crystal structure of ADAMTS13 CUB domains reveals their role in global latency","volume":"7","author":"Kim","year":"2021","journal-title":"Sci. Adv."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Singh, K., Sparring, T., Madarati, H., and Kretz, C.A. (2022). Review of our Current Understanding of ADAMTS13 and Von Willebrand Factor in Sepsis and Other Critical Illnesses. Biomarkers in Trauma, Injury and Critical Care, Springer.","DOI":"10.1007\/978-3-030-87302-8_36-1"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1111\/jth.13149","article-title":"Linker regions and flexibility around the metalloprotease domain account for conformational activation of ADAMTS-13","volume":"13","author":"Deforche","year":"2015","journal-title":"J. Thromb. Haemost."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"18578","DOI":"10.1073\/pnas.1411979112","article-title":"Conformational activation of ADAMTS13","volume":"111","author":"South","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_55","first-page":"201","article-title":"Von Willebrand Factor in Health and Disease","volume":"15","author":"Avdonin","year":"2021","journal-title":"Biochem. (Mosc.) Suppl. Ser. A Membr. Cell Biol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1055\/s-0038-1660505","article-title":"Effects of plasmin on von Willebrand factor and platelets: A narrative review","volume":"2","author":"Remijn","year":"2018","journal-title":"TH Open"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.thromres.2015.06.022","article-title":"ADAMTS13 gene variants and function in women with preeclampsia: A population-based nested case-control study from the HUNT study","volume":"136","author":"Hovinga","year":"2015","journal-title":"Thromb. Res."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Gyselaers, W. (2020). Preeclampsia is a syndrome with a cascade of pathophysiologic events. J. Clin. Med., 9.","DOI":"10.3390\/jcm9072245"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Rauch, A., Susen, S., and Zieger, B. (2019). Acquired von Willebrand Syndrome in Patients With Ventricular Assist Device. Front. Med., 6.","DOI":"10.3389\/fmed.2019.00007"},{"key":"ref_60","unstructured":"Zenner, H.L. (2007). The Biogenesis of Weibel-Palade Bodies. [Ph.D. Thesis, University of London]."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/10408363.2021.2014781","article-title":"Von Willebrand factor and disease: A review for laboratory professionals","volume":"59","author":"Harris","year":"2022","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1046\/j.1538-7836.2003.00260.x","article-title":"Von Willebrand factor, platelets and endothelial cell interactions","volume":"1","author":"Ruggeri","year":"2003","journal-title":"J. Thromb. Haemost."},{"key":"ref_63","first-page":"141","article-title":"Inflammation, von Willebrand factor, and ADAMTS13","volume":"132","author":"Chen","year":"2018","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.blre.2010.03.003","article-title":"The genetic basis of von Willebrand disease","volume":"24","author":"Goodeve","year":"2010","journal-title":"Blood Rev."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1182\/blood.2023021915","article-title":"Novel functions for Von Willebrand factor","volume":"144","author":"Atiq","year":"2024","journal-title":"Blood"},{"key":"ref_66","first-page":"2019","article-title":"von Willebrand factor biosynthesis, secretion, and clearance: Connecting the far ends","volume":"125","author":"Lenting","year":"2015","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_67","first-page":"3212","article-title":"Unraveling the scissile bond: How ADAMTS13 recognizes and cleaves von Willebrand factor","volume":"118","author":"Crawley","year":"2011","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s12185-022-03324-w","article-title":"COVID-19 microthrombosis: Unusually large VWF multimers are a platform for activation of the alternative complement pathway under cytokine storm","volume":"115","author":"Fujimura","year":"2022","journal-title":"Int. J. Hematol."},{"key":"ref_69","first-page":"1523","article-title":"The von Willebrand factor D\u2019 D3 assembly and structural principles for factor VIII binding and concatemer biogenesis","volume":"133","author":"Dong","year":"2019","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1126\/science.1170905","article-title":"Mechanoenzymatic cleavage of the ultralarge vascular protein von Willebrand factor","volume":"324","author":"Zhang","year":"2009","journal-title":"Science"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.bpj.2010.06.002","article-title":"The mechanism of VWF-mediated platelet GPIb\u03b1 binding","volume":"99","author":"Auton","year":"2010","journal-title":"Biophys. J."},{"key":"ref_72","unstructured":"Cortes, G.A., Moore, M.J., and El-Nakeep, S. (2024, July 15). Physiology, von Willebrand Factor. Available online: https:\/\/europepmc.org\/article\/NBK\/nbk559062."},{"key":"ref_73","first-page":"2297","article-title":"Crucial role for the VWF A1 domain in binding to type IV collagen","volume":"125","author":"Flood","year":"2015","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1038\/s41467-019-11474-5","article-title":"Crystal structure and substrate-induced activation of ADAMTS13","volume":"10","author":"Petri","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"15035","DOI":"10.1074\/jbc.M208977200","article-title":"Mapping the collagen-binding site in the von Willebrand factor-A3 domain","volume":"278","author":"Romijn","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_76","first-page":"1785","article-title":"Highly reinforced structure of a C-terminal dimerization domain in von Willebrand factor","volume":"123","author":"Zhou","year":"2014","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_77","first-page":"2575","article-title":"Autoantibody-resistant ADAMTS13 variant","volume":"137","author":"Miyata","year":"2021","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_78","first-page":"285","article-title":"Thrombosis and von Willebrand factor","volume":"Volume 1","author":"Shahidi","year":"2017","journal-title":"Thrombosis and Embolism: From Research to Clinical Practice"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/ncomms1385","article-title":"Calcium modulates force sensing by the von Willebrand factor A2 domain","volume":"2","author":"Jakobi","year":"2011","journal-title":"Nat. Commun."},{"key":"ref_80","unstructured":"Lynch, C. (2017). Unfolding of the von Willebrand Factor A2 Domain. [Ph.D. Thesis, Imperial College London]."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Sukumar, S., L\u00e4mmle, B., and Cataland, S.R. (2021). Thrombotic thrombocytopenic purpura: Pathophysiology, diagnosis, and management. J. Clin. Med., 10.","DOI":"10.3390\/jcm10030536"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Jikamo, B., Adefris, M., Azale, T., and Alemu, K. (2023). Incidence, trends and risk factors of preeclampsia in sub-Saharan Africa: A systematic review and meta-analysis. PAMJ One Health, 11.","DOI":"10.11604\/pamj-oh.2023.11.1.39297"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e056130","DOI":"10.1136\/bmjopen-2021-056130","article-title":"Exploring digital health interventions for pregnant women at high risk for pre-eclampsia and eclampsia in low-income and-middle-income countries: A scoping review","volume":"12","author":"Feroz","year":"2022","journal-title":"BMJ Open"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijgo.12802","article-title":"The International Federation of Gynecology and Obstetrics (FIGO) initiative on preeclampsia (PE): A pragmatic guide for first trimester screening and prevention","volume":"145","author":"Poon","year":"2019","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Yang, N., Wang, Q., Ding, B., Gong, Y., Wu, Y., Sun, J., Wang, X., Liu, L., Zhang, F., and Du, D. (2022). Expression profiles and functions of ferroptosis-related genes in the placental tissue samples of early-and late-onset preeclampsia patients. BMC Pregnancy Childbirth, 22.","DOI":"10.1186\/s12884-022-04423-6"},{"key":"ref_86","first-page":"1","article-title":"The differences of characteristic, management, maternal and perinatal outcomes among early and late onset preeclampsia","volume":"3","author":"Aziz","year":"2016","journal-title":"Open Access Libr. J."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"S9.e1","DOI":"10.1016\/j.ajog.2015.08.003","article-title":"Preeclampsia, biomarkers, syncytiotrophoblast stress, and placental capacity","volume":"213","author":"Redman","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/AOG.0000000000001424","article-title":"Risk of preeclampsia in human immunodeficiency virus\u2013infected pregnant women","volume":"127","author":"Sansone","year":"2016","journal-title":"Obstet. Gynecol."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Meazaw, M.W., Chojenta, C., Muluneh, M.D., and Loxton, D. (2020). Systematic and meta-analysis of factors associated with preeclampsia and eclampsia in sub-Saharan Africa. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0237600"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.22178\/pos.102-1","article-title":"Preeclampsia and the Associated Risk Factors Among Pregnant Women in Indonesia: A Literature Review","volume":"10","author":"Ari","year":"2024","journal-title":"Path Sci."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.preghy.2021.12.002","article-title":"Risk factors of preeclampsia among pregnant women admitted at labor ward of public hospitals, low income country of Ethiopia; case control study","volume":"27","author":"Demissie","year":"2022","journal-title":"Pregnancy Hypertens."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ajog.2019.05.044","article-title":"Placental bed research: I. The placental bed: From spiral arteries remodeling to the great obstetrical syndromes","volume":"221","author":"Brosens","year":"2019","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5830\/CVJA-2016-009","article-title":"Pre-eclampsia: Its pathogenesis and pathophysiolgy: Review articles","volume":"27","author":"Gathiram","year":"2016","journal-title":"Cardiovasc. J. Afr."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"632732","DOI":"10.1155\/2012\/632732","article-title":"Pathogenesis of preeclampsia: The genetic component","volume":"2012","author":"Valenzuela","year":"2012","journal-title":"J. Pregnancy"},{"key":"ref_95","unstructured":"Boyajian, T. (2010). Preeclampsia in HIV Positive Pregnant Women on Highly Active Anti-Retroviral Therapy: A Matched Cohort Study. [Master\u2019s Thesis, University of Toronto]."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1161\/HYPERTENSIONAHA.116.06421","article-title":"Angiogenic factors in preeclampsia: From diagnosis to therapy","volume":"67","author":"Karumanchi","year":"2016","journal-title":"Hypertension"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Fowkes, F.J., Draper, B.L., Hellard, M., and Stoov\u00e9, M. (2016). Achieving development goals for HIV, tuberculosis and malaria in sub-Saharan Africa through integrated antenatal care: Barriers and challenges. BMC Med., 14.","DOI":"10.1186\/s12916-016-0753-9"},{"key":"ref_98","unstructured":"Paudel, S., Baral, S., Yadav, R.K., Baral, Y.N., Yadav, D.K., Poudel, S., Khadka, K.B., Nagila, A., and Adhikari, B. (2023, June 16). Comorbidities and Factors Associated with Health-Related Quality of Life among People Living with HIV\/AIDS in Gandaki Province of Nepal. Available online: https:\/\/assets-eu.researchsquare.com\/files\/rs-3924682\/v1\/823c1845-36bf-40be-968a-1b4df2e6f0fc.pdf."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Zuma, K., Simbayi, L., Zungu, N., Moyo, S., Marinda, E., Jooste, S., North, A., Nadol, P., Aynalem, G., and Igumbor, E. (2022). The HIV epidemic in South Africa: Key findings from 2017 national population-based survey. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph19138125"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijregi.2022.08.009","article-title":"HIV and adolescent girls and young women in sub-Saharan Africa: A call for expedited action to reduce new infections","volume":"5","author":"Murewanhema","year":"2022","journal-title":"IJID Reg."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Woldesenbet, S., Kufa-Chakezha, T., Lombard, C., Manda, S., Cheyip, M., Ayalew, K., Chirombo, B., Barron, P., Diallo, K., and Parekh, B. (2021). Recent HIV infection among pregnant women in the 2017 antenatal sentinel cross\u2013sectional survey, South Africa: Assay\u2013based incidence measurement. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0249953"},{"key":"ref_102","unstructured":"Mthembu, M.H. (2019). The Role of Endothelin-1 in HIV Associated Pre-Eclampsia. [Master\u2019s Thesis, University of KwaZulu-Natal]."},{"key":"ref_103","unstructured":"UNIAIDS (2024, May 15). Global HIV & AIDS Statistics\u2014Fact Sheet. 17 July 2023. Available online: https:\/\/www.unaids.org\/en\/resources\/fact-sheet."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jtbi.2012.05.013","article-title":"HIV evolution and progression of the infection to AIDS","volume":"307","author":"Huang","year":"2012","journal-title":"J. Theor. Biol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0140-6736(14)60164-1","article-title":"HIV infection: Epidemiology, pathogenesis, treatment, and prevention","volume":"384","author":"Maartens","year":"2014","journal-title":"Lancet"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Zayas, J.P., and Mamede, J.I. (2022). HIV infection and spread between Th17 cells. Viruses, 14.","DOI":"10.3390\/v14020404"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1111\/jth.15502","article-title":"von Willebrand factor propeptide-to-antigen ratio in HIV-infected pregnancy: Evidence of endothelial activation","volume":"19","author":"Schapkaitz","year":"2021","journal-title":"J. Thromb. Haemost."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Naicker, T., Govender, N., Abel, T., Naidoo, N., Moodley, M., Pillay, Y., Singh, S., Khaliq, O.P., and Moodley, J. (2021). HIV associated preeclampsia: A multifactorial appraisal. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22179157"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21037\/arh.2019.02.01","article-title":"Endothelial dysfunction in HIV infection: Experimental and clinical evidence on the role of oxidative stress","volume":"3","author":"Margaritis","year":"2019","journal-title":"Ann. Res. Hosp."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1097\/QAD.0000000000003607","article-title":"Evaluating the association of antiretroviral therapy and immune status with hypertensive disorders of pregnancy among people with HIV","volume":"37","author":"Yee","year":"2023","journal-title":"AIDS"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ejogrb.2020.11.034","article-title":"HIV in pregnancy\u2014An update","volume":"256","author":"Chilaka","year":"2021","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Schank, M., Zhao, J., Moorman, J.P., and Yao, Z.Q. (2021). The impact of HIV-and ART-induced mitochondrial dysfunction in cellular senescence and aging. Cells, 10.","DOI":"10.3390\/cells10010174"},{"key":"ref_113","first-page":"229","article-title":"Adverse effects of antiretroviral therapy for HIV infection","volume":"170","author":"Montessori","year":"2004","journal-title":"CMAJ"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4102\/sajhivmed.v21i1.1115","article-title":"Southern African HIV Clinicians Society guidelines for antiretroviral therapy in adults: 2020 update","volume":"21","author":"Nel","year":"2020","journal-title":"S. Afr. J. HIV Med."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1136\/bmj.39176.674977.AD","article-title":"HIV and pregnancy","volume":"334","author":"Gray","year":"2007","journal-title":"BMJ"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Cerveny, L., Murthi, P., and Staud, F. (2021). HIV in pregnancy: Mother-to-child transmission, pharmacotherapy, and toxicity. Biochim. Biophys. Acta (BBA) Mol. Basis Dis., 1867.","DOI":"10.1016\/j.bbadis.2021.166206"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41440-020-00604-y","article-title":"Maternal endothelial dysfunction in HIV-associated preeclampsia comorbid with COVID-19: A review","volume":"44","author":"Naidoo","year":"2021","journal-title":"Hypertens. Res."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0140-6736(15)00838-7","article-title":"Global, regional, and national levels and trends in maternal mortality between 1990 and 2015, with scenario-based projections to 2030: A systematic analysis by the UN Maternal Mortality Estimation Inter-Agency Group","volume":"387","author":"Alkema","year":"2016","journal-title":"Lancet"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"3864941","DOI":"10.1155\/2020\/3864941","article-title":"The role of inflammation in the pathogenesis of preeclampsia","volume":"2020","author":"Michalczyk","year":"2020","journal-title":"Mediat. Inflamm."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Aneman, I., Pienaar, D., Suvakov, S., Simic, T.P., Garovic, V.D., and McClements, L. (2020). Mechanisms of key innate immune cells in early-and late-onset preeclampsia. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.01864"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00011-019-01240-0","article-title":"The role of the complement system in HIV infection and preeclampsia","volume":"68","author":"Pillay","year":"2019","journal-title":"Inflamm. Res."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Geldenhuys, J., Rossouw, T.M., Lombaard, H.A., Ehlers, M.M., and Kock, M.M. (2018). Disruption in the regulation of immune responses in the placental subtype of preeclampsia. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.01659"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000491087","article-title":"Placental proinflammatory state and maternal endothelial dysfunction in preeclampsia","volume":"84","author":"Saucedo","year":"2019","journal-title":"Gynecol. Obstet. Investig."},{"key":"ref_124","unstructured":"Govender, S. (2020). The Role of Complement Components C2 and C5a in HIV Associated Preeclampsia. [Ph.D. Thesis, University of KwaZulu-Natal]."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Naicker, T., Phoswa, W.N., Onyangunga, O.A., Gathiram, P., and Moodley, J. (2019). Angiogenesis, lymphangiogenesis, and the immune response in South African preeclamptic women receiving HAART. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20153728"},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Mu, W., Patankar, V., Kitchen, S., and Zhen, A. (2024). Examining chronic inflammation, immune metabolism, and T cell dysfunction in HIV infection. Viruses, 16.","DOI":"10.3390\/v16020219"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11904-017-0356-x","article-title":"Inflammation, immune activation, and antiretroviral therapy in HIV","volume":"14","author":"Hileman","year":"2017","journal-title":"Curr. Hiv\/Aids Rep."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Abel, T., Moodley, J., Khaliq, O.P., and Naicker, T. (2022). Vascular Endothelial Growth Factor Receptor 2: Molecular Mechanism and Therapeutic Potential in Preeclampsia Comorbidity with Human Immunodeficiency Virus and Severe Acute Respiratory Syndrome Coronavirus 2 Infections. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232213752"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.atherosclerosis.2009.07.029","article-title":"Non-nucleoside reverse transcriptase inhibitor efavirenz increases monolayer permeability of human coronary artery endothelial cells","volume":"208","author":"Jamaluddin","year":"2010","journal-title":"Atherosclerosis"},{"key":"ref_130","first-page":"37","article-title":"In silico Studies on N-(Pyridin-2-yl) Thiobenzamides as NNRTIs against Wild and Mutant HIV-1 Strains","volume":"147","author":"Singh","year":"2018","journal-title":"Philipp. J. Sci."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000487534","article-title":"Beneficial and detrimental effects of antiretroviral therapy on HIV-associated immunosenescence","volume":"63","author":"Franzese","year":"2018","journal-title":"Chemotherapy"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"e126675","DOI":"10.1172\/jci.insight.126675","article-title":"Effect of HIV infection and antiretroviral therapy on immune cellular functions","volume":"4","author":"Korencak","year":"2019","journal-title":"JCI Insight"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1007\/s00018-010-0346-2","article-title":"Retroviral reverse transcriptases","volume":"67","author":"Herschhorn","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ejmech.2015.11.025","article-title":"Efavirenz a nonnucleoside reverse transcriptase inhibitor of first-generation: Approaches based on its medicinal chemistry","volume":"108","author":"Bastos","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ejogrb.2020.06.016","article-title":"Morphometric image analysis of vascular endothelial growth factor receptor-3 in preeclamptic, HIV infected women","volume":"253","author":"Pillay","year":"2020","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.2174\/1568026619666190619115243","article-title":"Protease inhibitors for the treatment of HIV\/AIDS: Recent advances and future challenges","volume":"19","author":"Voshavar","year":"2019","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_137","unstructured":"Castro-Guill\u00e9n, J.L., Garc\u00eda-Gasca, T., and Blanco-Labra, A. (2010). Protease inhibitors as anticancer agents. New Approaches in the Treatment of Cancer, Nova Science Publishers."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1016\/S2352-3018(21)00249-6","article-title":"Protease inhibitor-based antiretroviral therapy in pregnancy: Effects on hormones, placenta, and decidua","volume":"9","author":"Dunk","year":"2022","journal-title":"Lancet HIV"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1093\/humrep\/deaa151","article-title":"Periconceptional exposure to lopinavir, but not darunavir, impairs decidualization: A potential mechanism leading to poor birth outcomes in HIV-positive pregnancies","volume":"35","author":"Kala","year":"2020","journal-title":"Hum. Reprod."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11904-019-00480-3","article-title":"Recent advances in the development of integrase inhibitors for HIV treatment","volume":"17","author":"Trivedi","year":"2020","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2174\/157016212803306032","article-title":"Immune reconstitution in HIV+ subjects on lopinavir\/ritonavir-based HAART according to the severity of pre-therapy CD4+","volume":"10","author":"Marchetti","year":"2012","journal-title":"Curr. HIV Res."},{"key":"ref_142","first-page":"42","article-title":"Term Pregnancy Woman with Human Immunodeficiency Virus Infection and Antiretroviral Therapy as Risk Factor of High Caspase-3 Expression in Placenta","volume":"4","author":"Prasetyo","year":"2022","journal-title":"Eur. J. Med. Health Sci."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Wu, T., Zhou, K., Hua, Y., Zhang, W., and Li, Y. (2023). The molecular mechanisms in prenatal drug exposure-induced fetal programmed adult cardiovascular disease. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1164487"},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Mohammadi, H., Papp, E., Cahill, L., Rennie, M., Banko, N., Pinnaduwage, L., Lee, J., Kibschull, M., Dunk, C., and Sled, J.G. (2018). HIV antiretroviral exposure in pregnancy induces detrimental placenta vascular changes that are rescued by progesterone supplementation. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-24680-w"},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Oliveira, M., de Moraes Salgado, C., Viana, L.R., and Cintra Gomes-Marcondes, M.C.C. (2021). Pregnancy and Cancer: Cellular Biology and Mechanisms Affecting the Placenta. Cancers, 13.","DOI":"10.3390\/cancers13071667"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"224","DOI":"10.5603\/GP.a2021.0096","article-title":"First trimester screening and progesterone levels in HIV positive women under HAART therapy","volume":"93","author":"Iasi","year":"2022","journal-title":"Ginekol. Polska"},{"key":"ref_147","first-page":"94","article-title":"Placental Structure in Preterm Birth Among HIV-Positive Versus HIV-Negative Women in Kenya","volume":"80","author":"Obimbo","year":"2019","journal-title":"Am. J. Ther."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1046\/j.1523-1755.63.6s.1.x","article-title":"Mutation analysis and clinical implications of von Willebrand factor\u2013cleaving protease deficiency","volume":"63","author":"Assink","year":"2003","journal-title":"Kidney Int."},{"key":"ref_149","unstructured":"Feys, H. (2006). Insights into thrombotic thrombocytopenic purpura by monoclonal antibody-based analysis of the Von Willebrand factor cleaving protease, ADAMTS-13. [Ph.D. Thesis, Katholieke Universiteit Leuven Associatie Kortrijk]."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/jca.21366","article-title":"Congenital and acquired ADAMTS13 deficiency: Two mechanisms, one patient","volume":"30","author":"Ferrari","year":"2015","journal-title":"J. Clin. Apher."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.thromres.2014.09.004","article-title":"Inherited ADAMTS13 deficiency (Upshaw-Schulman syndrome): A short review","volume":"134","author":"Batlle","year":"2014","journal-title":"Thromb. Res."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/ejh.12197","article-title":"Congenital thrombotic thrombocytopenic purpura caused by new compound heterozygous mutations of the ADAMTS 13 gene","volume":"92","author":"Rank","year":"2014","journal-title":"Eur. J. Haematol."},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Bashir, B.A., Mohamed, M.H., Hussain, M.A., Osman, W., Mothana, R.A., and Hasson, S. (2023). Trends of Coagulation Parameters in Human Immunodeficiency Virus Patients. Medicina, 59.","DOI":"10.3390\/medicina59101826"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s12185-009-0481-4","article-title":"Pivotal role of ADAMTS13 function in liver diseases","volume":"91","author":"Uemura","year":"2010","journal-title":"Int. J. Hematol."},{"key":"ref_155","first-page":"5364","article-title":"Synonymous ADAMTS13 variants impact molecular characteristics and contribute to variability in active protein abundance","volume":"6","author":"Jankowska","year":"2022","journal-title":"Blood Adv."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"giab023","DOI":"10.1093\/gigascience\/giab023","article-title":"Synonymous variants that disrupt messenger RNA structure are significantly constrained in the human population","volume":"10","author":"Gaither","year":"2021","journal-title":"GigaScience"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1182\/bloodadvances.2017005629","article-title":"Genetic variants in ADAMTS13 as well as smoking are major determinants of plasma ADAMTS13 levels","volume":"1","author":"Ma","year":"2017","journal-title":"Blood Adv."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1111\/jcmm.15025","article-title":"Novel mutations in ADAMTS13 CUB domains cause abnormal pre-mRNA splicing and defective secretion of ADAMTS13","volume":"24","author":"Jiang","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"ref_159","first-page":"1644","article-title":"Characterization and treatment of congenital thrombotic thrombocytopenic purpura","volume":"133","author":"Alwan","year":"2019","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.hoc.2021.07.010","article-title":"Rare coagulation factor deficiencies (factors VII, X, V, and II)","volume":"35","author":"Batsuli","year":"2021","journal-title":"Hematol. Oncol. Clin."},{"key":"ref_161","unstructured":"Patton, L.L. (2003). Bleeding and clotting disorders. Burket\u2019s Oral Medicine: Diagnosis and Treatment, BC Decker. [10th ed.]."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1111\/j.1538-7836.2005.01369.x","article-title":"von Willebrand factor: Two sides of a coin","volume":"3","author":"Sadler","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1172\/JCI69458","article-title":"von Willebrand factor mutation promotes thrombocytopathy by inhibiting integrin \u03b1IIb\u03b23","volume":"123","author":"Casari","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/hae.13175","article-title":"Molecular diagnosis of von Willebrand disease","volume":"23","author":"Baronciani","year":"2017","journal-title":"Haemophilia"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"89","DOI":"10.17925\/EOH.2012.08.02.89","article-title":"HIV-associated thrombotic thrombocytopenic purpura\u2013what we know so far","volume":"8","author":"Meiring","year":"2012","journal-title":"Eur. Oncol. Haematol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1111\/trf.14804","article-title":"ADAMTS13: Origins, applications, and prospects","volume":"58","author":"Plautz","year":"2018","journal-title":"Transfusion"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"276","DOI":"10.7150\/ijms.28110","article-title":"Von Willebrand factor adhesive activity and ADAMTS13 protease activity in HIV-1-infected men","volume":"16","author":"Graham","year":"2019","journal-title":"Int. J. Med. Sci."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/hiv.12310","article-title":"Immune activation in the course of HIV-1 infection: Causes, phenotypes and persistence under therapy","volume":"17","author":"Younas","year":"2016","journal-title":"HIV Med."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-1293.2012.01027.x","article-title":"Endothelial dysfunction, increased inflammation, and activated coagulation in HIV-infected patients improve after initiation of highly active antiretroviral therapy","volume":"14","author":"Arildsen","year":"2013","journal-title":"HIV Med."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1038\/s41440-023-01314-x","article-title":"Differential expression of the angiotensin receptors (AT1, AT2, and AT4) in the placental bed of HIV-infected preeclamptic women of African ancestry","volume":"46","author":"Singh","year":"2023","journal-title":"Hypertens. Res."},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Pretorius, E. (2021). Platelets in HIV: A guardian of host defence or transient reservoir of the virus?. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.649465"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/COH.0000000000000019","article-title":"Markers of coagulation and inflammation often remain elevated in ART-treated HIV-infected patients","volume":"9","author":"Funderburg","year":"2014","journal-title":"Curr. Opin. HIV AIDS"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12981-016-0105-z","article-title":"What happens to cardiovascular system behind the undetectable level of HIV viremia?","volume":"13","author":"Ceccarelli","year":"2016","journal-title":"AIDS Res. Ther."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7827-5-6","article-title":"Control of human trophoblast function","volume":"5","author":"Lunghi","year":"2007","journal-title":"Reprod. Biol. Endocrinol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/aji.12466","article-title":"Decidual control of trophoblast invasion","volume":"75","author":"Sharma","year":"2016","journal-title":"Am. J. Reprod. Immunol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1161\/ATVBAHA.117.309735","article-title":"Expression of ADAMTS13 in normal and abnormal placentae and its potential role in angiogenesis and placenta development","volume":"37","author":"Xiao","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nrm3904","article-title":"Remodelling the extracellular matrix in development and disease","volume":"15","author":"Bonnans","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Niland, S., Riscanevo, A.X., and Eble, J.A. (2021). Matrix metalloproteinases shape the tumor microenvironment in cancer progression. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23010146"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1097\/01.CCM.0000284508.05247.B3","article-title":"Decreased ADAMTS-13 (A disintegrin-like and metalloprotease with thrombospondin type 1 repeats) is associated with a poor prognosis in sepsis-induced organ failure","volume":"35","author":"Martin","year":"2007","journal-title":"Crit. Care Med."},{"key":"ref_180","first-page":"211","article-title":"Thrombotic thrombocytopenic purpura and pregnancy: Presentation, management, and subsequent pregnancy outcomes","volume":"124","author":"Scully","year":"2014","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.mvr.2012.05.004","article-title":"ADAMTS13 promotes angiogenesis and modulates VEGF-induced angiogenesis","volume":"84","author":"Lee","year":"2012","journal-title":"Microvasc. Res."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1016\/j.ekir.2024.05.016","article-title":"Thrombotic microangiopathy in pregnancy: Current understanding and management strategies","volume":"9","author":"Urra","year":"2024","journal-title":"Kidney Int. Rep."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"38","DOI":"10.4067\/S0717-95022021000100038","article-title":"Expresi\u00f3n de ADAMTS13 y PCNA en las Placentas de Madres Diab\u00e9ticas Gestacionales","volume":"39","author":"Oglak","year":"2021","journal-title":"Int. J. Morphol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1179\/1607845412Y.0000000070","article-title":"Increased VWF antigen levels and decreased ADAMTS13 activity in preeclampsia","volume":"18","author":"Aref","year":"2013","journal-title":"Hematology"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2174\/156652410790963367","article-title":"The balance between von-Willebrand factor and its cleaving protease ADAMTS13: Biomarker in systemic inflammation and development of organ failure?","volume":"10","author":"Claus","year":"2010","journal-title":"Curr. Mol. Med."},{"key":"ref_186","doi-asserted-by":"crossref","unstructured":"Karim, F., Adil, S.N., Afaq, B., and Haq, A. (2013). Deficiency of ADAMTS-13 in pediatric patients with severe sepsis and impact on in-hospital mortality. BMC Pediatr., 13.","DOI":"10.1186\/1471-2431-13-44"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"102422","DOI":"10.1016\/j.jogoh.2022.102422","article-title":"Thrombotic thrombocytopenic purpura and severe preeclampsia: A clinical overlap during pregnancy and a possible coexistence","volume":"51","author":"Dap","year":"2022","journal-title":"J. Gynecol. Obstet. Hum. Reprod."},{"key":"ref_188","doi-asserted-by":"crossref","unstructured":"Berube, C., and Dietrich, B. (2017). Ask the Hematologists: Von Willebrand Disease and Pregnancy. Hematol., 14.","DOI":"10.1182\/hem.V14.3.7296"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ajog.2010.02.036","article-title":"Von Willebrand disease and pregnancy: A practical approach for the diagnosis and treatment","volume":"203","author":"Pacheco","year":"2010","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_190","doi-asserted-by":"crossref","unstructured":"Warren, B.B., Moyer, G.C., and Manco-Johnson, M.J. (2023). Hemostasis in the pregnant woman, the placenta, the fetus, and the newborn infant. Seminars in Thrombosis and Hemostasis, Thieme Medical Publishers, Inc.","DOI":"10.1055\/s-0042-1760332"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"39","DOI":"10.7754\/Clin.Lab.2014.140521","article-title":"Markers of endothelial activation in preeclampsia","volume":"61","author":"Prochazka","year":"2015","journal-title":"Clin. Lab."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/hae.14547","article-title":"von Willebrand disease and von Willebrand factor","volume":"28","author":"Sadler","year":"2022","journal-title":"Haemophilia"},{"key":"ref_193","first-page":"941","article-title":"Plasma levels of von Willebrand factor and fibronectin as markers of persisting endothelial damage in preeclampsia","volume":"84","author":"Deng","year":"1994","journal-title":"Obstet. Gynecol."},{"key":"ref_194","doi-asserted-by":"crossref","unstructured":"Petca, A., Miron, B.C., Pacu, I., Dumitra\u0219cu, M.C., Mehedin\u021bu, C., \u0218andru, F., Petca, R.C., and Rotar, J.C. (2022). HELLP syndrome\u2014Holistic insight into pathophysiology. Medicina, 58.","DOI":"10.3390\/medicina58020326"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"e7557","DOI":"10.1002\/ccr3.7557","article-title":"HELLP syndrome complicated by ischemic colitis: A case report","volume":"11","author":"Boustani","year":"2023","journal-title":"Clin. Case Rep."},{"key":"ref_196","doi-asserted-by":"crossref","unstructured":"Lewandowska, M., Englert-Golon, M., Krasi\u0144ski, Z., Jagodzi\u0144ski, P.P., and Sajdak, S. (2022). A Rare Case of HELLP Syndrome with Hematomas of Spleen and Liver, Eclampsia, Severe Hypertension and Prolonged Coagulopathy\u2014A Case Report. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph19137681"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/cphy.c200008","article-title":"Preeclampsia: Linking placental ischemia with maternal endothelial and vascular dysfunction","volume":"11","author":"Bakrania","year":"2020","journal-title":"Compr. Physiol."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bcp.2015.04.012","article-title":"Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia","volume":"95","author":"Shah","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/35097008","article-title":"Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura","volume":"413","author":"Levy","year":"2001","journal-title":"Nature"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.atherosclerosis.2009.04.013","article-title":"Lower levels of ADAMTS13 are associated with cardiovascular disease in young patients","volume":"207","author":"Bongers","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref_201","doi-asserted-by":"crossref","unstructured":"Larkin, D., de Laat, B., Jenkins, P.V., Bunn, J., Craig, A.G., Terraube, V., Preston, R.J.S., Donkor, C., Grau, G.E., and van Mourik, J.A. (2009). Severe Plasmodium falciparum malaria is associated with circulating ultra-large von Willebrand multimers and ADAMTS13 inhibition. PLoS Pathog., 5.","DOI":"10.1371\/journal.ppat.1000349"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11906-023-01258-0","article-title":"Irregularities of Coagulation in Hypertension","volume":"25","author":"Rafaqat","year":"2023","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1097\/01.HS9.0000849648.14082.17","article-title":"P1698: Increased Complement Activation and Decreased ADAMTS13 Activity in Patients with Pre-Eclampsia Compared to Healthy Pregnancies","volume":"6","author":"Venou","year":"2022","journal-title":"Hemasphere"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"100075","DOI":"10.1016\/j.rpth.2023.100075","article-title":"Preeclampsia: Platelet procoagulant membrane dynamics and critical biomarkers","volume":"7","author":"Agbani","year":"2023","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/febs.14657","article-title":"Vascular endothelial dysfunction in the wake of HIV and ART","volume":"286","author":"Marincowitz","year":"2019","journal-title":"FEBS J."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2174\/18756212MTA1oOTYh3","article-title":"Endothelial dysfunction and inflammatory markers of vascular disease","volume":"19","author":"Balta","year":"2021","journal-title":"Curr. Vasc. Pharmacol."},{"key":"ref_207","unstructured":"Allie, S. (2013). The role of von Willebrand factor and its cleaving protease, ADAMTS13, in young patients with HIV-related stroke. [Master\u2019s Thesis, University of Cape Town]."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"134","DOI":"10.5830\/CVJA-2010-056","article-title":"Is HIV-1 infection associated with endothelial dysfunction in a population of African ancestry in South Africa? Cardiovascular topics","volume":"22","author":"Fourie","year":"2011","journal-title":"Cardiovasc. J. Afr."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2337\/dc08-1865","article-title":"Factors contributing to increased platelet reactivity in people with diabetes","volume":"32","author":"Schneider","year":"2009","journal-title":"Diabetes Care"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"100694","DOI":"10.1016\/j.blre.2020.100694","article-title":"Platelet activation and prothrombotic mediators at the nexus of inflammation and atherosclerosis: Potential role of antiplatelet agents","volume":"45","author":"Lordan","year":"2021","journal-title":"Blood Rev."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12185-009-0476-1","article-title":"Pathophysiology of thrombotic thrombocytopenic purpura","volume":"91","author":"Tsai","year":"2010","journal-title":"Int. J. Hematol."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1111\/j.1538-7836.2006.02205.x","article-title":"Acute activation of the endothelium results in increased levels of active von Willebrand factor in hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome","volume":"4","author":"Hulstein","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1160\/TH08-05-0330","article-title":"Increased plasma von Willebrand factor antigen levels but normal von Willebrand factor cleaving protease (ADAMTS13) activity in preeclampsia","volume":"101","author":"Molvarec","year":"2009","journal-title":"Thromb. Haemost."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12959-018-0189-x","article-title":"Thrombotic thrombocytopenic purpura (TTP)-like syndrome in the HIV era","volume":"16","author":"Louw","year":"2018","journal-title":"Thromb. J."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"253","DOI":"10.5468\/ogs.22175","article-title":"The complement system in preeclampsia: A review of its activation and endothelial injury in the triad of COVID-19 infection and HIV-associated preeclampsia","volume":"66","author":"David","year":"2023","journal-title":"Obstet. Gynecol. Sci."},{"key":"ref_216","doi-asserted-by":"crossref","unstructured":"Govender, S., David, M., and Naicker, T. (2024). Is the Complement System Dysregulated in Preeclampsia Comorbid with HIV Infection?. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25116232"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/QAD.0b013e328325a87c","article-title":"HIV type 1 infection, and not short-term HAART, induces endothelial dysfunction","volume":"23","author":"Francisci","year":"2009","journal-title":"AIDS"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1111\/jth.12310","article-title":"Hypoxia, such as encountered at high altitude, promotes deep vein thrombosis in mice","volume":"11","author":"Brill","year":"2013","journal-title":"J. Thromb. Haemost."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1164\/rccm.201806-1170OC","article-title":"Evidence for the fucoidan\/P-selectin axis as a therapeutic target in hypoxia-induced pulmonary hypertension","volume":"199","author":"Novoyatleva","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.thromres.2007.03.011","article-title":"The role of von Willebrand factor in thrombus formation","volume":"120","author":"Ruggeri","year":"2007","journal-title":"Thromb. Res."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1073\/pnas.061307098","article-title":"Defect in regulated secretion of P-selectin affects leukocyte recruitment in von Willebrand factor-deficient mice","volume":"98","author":"Denis","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_222","first-page":"25","article-title":"P-Selectin Expression in HIV-Associated Coagulopathy: Implications for Treatment","volume":"2","author":"Obeagu","year":"2024","journal-title":"Elite J. Haematol."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"2183472","DOI":"10.1080\/14767058.2023.2183472","article-title":"Evaluation of maternal serum SERPINC1, E-selectin, P-selectin, RBP4 and PP13 levels in pregnancies complicated with preeclampsia","volume":"36","author":"Palalioglu","year":"2023","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/BF02015318","article-title":"Differential thrombogenicity of artery and vein: The role of von Willebrand factor","volume":"9","author":"Cho","year":"1995","journal-title":"Ann. Vasc. Surg."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/jth.15191","article-title":"The ADAMTS13-von Willebrand factor axis in COVID-19 patients","volume":"19","author":"Mancini","year":"2021","journal-title":"J. Thromb. Haemost."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"741.e1","DOI":"10.1016\/j.ajog.2020.05.026","article-title":"Platelet activation and placenta-mediated adverse pregnancy outcomes: An ancillary study to the Effects of Aspirin in Gestation and Reproduction trial","volume":"223","author":"Theilen","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/1471-0528.16552","article-title":"Association of placenta-derived extracellular vesicles with pre-eclampsia and associated hypercoagulability: A clinical observational study","volume":"128","author":"Chen","year":"2021","journal-title":"BJOG Int. J. Obstet. Gynaecol."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s11596-010-0657-4","article-title":"Von Willebrand factor antigen and ADAMTS13 activity assay in pregnant women and severe preeclamptic patients","volume":"30","author":"Zhang","year":"2010","journal-title":"J. Huazhong Univ. Sci. Technol. (Med. Sci.)"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/j.cca.2011.07.030","article-title":"ADAMTS13, FVIII, von Willebrand factor, ABO blood group assessment in preeclampsia","volume":"412","author":"Alpoim","year":"2011","journal-title":"Clin. Chim. Acta"},{"key":"ref_230","doi-asserted-by":"crossref","unstructured":"van den Dries, L.W., Gruters, R.A., H\u00f6vels\u2013van der Borden, S.B.C., Kruip, J.H.A., de Maat, P.M., Van Gorp, C.M., and van der Ende, E. (2015). von Willebrand Factor is elevated in HIV patients with a history of thrombosis. Front. Microbiol., 6.","DOI":"10.3389\/fmicb.2015.00180"},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/10641955.2017.1397690","article-title":"ADAMTS 1, 4, 12, and 13 levels in maternal blood, cord blood, and placenta in preeclampsia","volume":"37","author":"Kalem","year":"2018","journal-title":"Hypertens. Pregnancy"},{"key":"ref_232","doi-asserted-by":"crossref","unstructured":"Graham, S.M., Nance, R.M., Chen, J., Le, J., Chung, D.W., Wurfel, M.M., Tirschwell, D.L., Zunt, J.R., Marra, C.M., and Ho, E. (2021). Elevated plasma von Willebrand factor levels are associated with subsequent ischemic stroke in persons with treated HIV infection. Open Forum Infectious Diseases, Oxford University Press.","DOI":"10.1093\/ofid\/ofab521"},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1080\/25787489.2021.1975608","article-title":"HIV and COVID-19: Review of clinical course and outcomes","volume":"22","author":"Barbera","year":"2021","journal-title":"HIV Res. Clin. Pract."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"102459","DOI":"10.1016\/j.jogoh.2022.102459","article-title":"Risk of preeclampsia in patients with symptomatic COVID-19 infection","volume":"51","author":"Tran","year":"2022","journal-title":"J. Gynecol. Obstet. Hum. Reprod."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"H87","DOI":"10.1152\/ajpheart.00204.2021","article-title":"Contribution of the von Willebrand factor\/ADAMTS13 imbalance to COVID-19 coagulopathy","volume":"322","author":"Seth","year":"2022","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"100760","DOI":"10.1016\/j.ajogmf.2022.100760","article-title":"Confirmation of preeclampsia-like syndrome induced by severe COVID-19: An observational study","volume":"5","author":"Serrano","year":"2023","journal-title":"Am. J. Obstet. Gynecol. MFM"},{"key":"ref_237","doi-asserted-by":"crossref","unstructured":"Coronado-Arroyo, J.C., Concepci\u00f3n-Zavaleta, M.J., Zavaleta-Guti\u00e9rrez, F.E., and Concepci\u00f3n-Urteaga, L.A. (2021). Is COVID-19 a risk factor for severe preeclampsia? Hospital experience in a developing country. Eur. J. Obstet. Gynecol. Reprod. Biol., 256.","DOI":"10.1016\/j.ejogrb.2020.09.020"},{"key":"ref_238","doi-asserted-by":"crossref","unstructured":"Zhang, Q., Bignotti, A., Yada, N., Ye, Z., Liu, S., Han, Z., and Zheng, X.L. (2023). Dynamic Assessment of Plasma von Willebrand Factor and ADAMTS13 Predicts Mortality in Hospitalized Patients with SARS-CoV-2 Infection. J. Clin. Med., 12.","DOI":"10.20944\/preprints202308.1778.v1"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/9\/4103\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:21:52Z","timestamp":1760030512000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/9\/4103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":238,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["ijms26094103"],"URL":"https:\/\/doi.org\/10.3390\/ijms26094103","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,25]]}}}